This Autumn Phlexglobal will host the annual TMF World Forum, two exciting events focused on helping the life science industry, including pharmaceutical companies, clinical research organizations, and medical device manufacturers, meet compliance standards, achieve ongoing TMF Health, and become consistently inspection-ready: what the company refers to as “Reaching the TMF Health Zone.”
Phlexglobal today announced an important industry advisory around the new European Medicines Agency (EMA) guidance on Trial Master Files. The guidance took effect on June 6, 2019, and promises to have far-reaching impacts on an organization’s TMF processes, technology, and best practices – as well as related departments and systems.
Generis, Phlexglobal and LORENZ Life Sciences Group, announce the founding of the Alliance of Experts, a new source for end-to-end Regulatory Information Management (RIM) and Clinical solutions in Life Sciences. The Alliance of Experts brings the expertise of each company together to provide seamless interoperability between their software packages, providing customers a 'single source of truth' for all data that can be used and applied in multiple solutions.
Phlexglobal today announced that its Board of Directors has appointed John McNeill as Chief Executive Officer and member of the Board of Directors effective January 14, 2019. McNeill previously held the position of President at Sparta Systems, Inc.
Phlexglobal, a specialist provider of technology-enabled Trial Master File (TMF & eTMF) management solutions, is adopting Version 1 of the eTMF Exchange Mechanism Standard (eTMF-EMS) of the TMF Reference Model (TMF-RM) into PhlexEview, the company’s eTMF technology. This marks a major advancement in efficient document interchange and will firmly solidify Phlexglobal’s position as a driving force in eTMF management for clinical trials.